(b)(4).Method: when this incident was reported to us, further information was sought from the reporter.We were informed that the patient was admitted to a hospice and died there, and that no direct connection had not been established between the patient's death and use of the airvo.We were also informed that pulse oximetry was being used to monitor the patient's blood-oxygen saturation, which is in line with our user instructions.Both of the complaint airvo humidifiers were received at fisher & paykel healthcare new zealand.Devices (b)(4).Both devices were manufactured on 17 april 2013.The complaint airvos were visually inspected and performance tested.Results: device 1: the airvo¿ tube was attached to the unit and a normal cycle was started.Power was applied and the unit was turned on and operated, and shortly after displayed an 'oxygen too high' alarm.The unit was opened for further inspection and the fault was traced to a faulty sensor.Device 2: the airvo settings were adjusted to match the settings used to treat the patient and test run for 12 hours, during which time it did not shut off or display any errors.The unit was also tested at 122 volts for 27 hours and during this time no power out issues arose.Conclusion: device 1 had an oxygen sensor fault.This would have caused the airvo to display an alarm, but would not have affected the therapy being delivered to the patient.Device 2 operated correctly during testing and did not shut down at any time.While we were not informed of the cause of death we have been told that the patient had congenital heart and lung defects so severe that ecmo treatment was required to keep the patient alive during the first month of life.There is no evidence to suggest that the airvo units caused or contributed to the death of the patient.The airvo 2 user manual instructs the user to "use continuous oxygen monitoring on patients who would desaturate significantly in the event of disruption to their oxygen supply." our user instructions that accompany the airvo humidifier state that "the airvo 2 is for the treatment of spontaneously breathing patients (adult and pediatric > 3 kg) who would benefit from receiving high flow warmed and humidified respiratory gases." they also state: "the unit is not intended for life support.".
|